BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37043980)

  • 41. [Effect of butyl alcohol extract of Baitouweng Decoction on epithelial barrier of vaginal mucosa in mice with vulvovaginal candidiasis].
    Ting Z; Ya-Dong W; Kang Z; Meng-Xiang Z; Qiang-Jun D; Tian-Ming W; Jing S; Chang-Zhong W
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4991-4996. PubMed ID: 33350274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis.
    Feng W; Yang J; Ji Y; Xi Z; Yang L; Zhu X; Ma Y
    Lett Appl Microbiol; 2020 Feb; 70(2):95-101. PubMed ID: 31705810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
    Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
    Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The in vivo anti-Candida albicans activity of flavonoids.
    Nguyen W; Grigori L; Just E; Santos C; Seleem D
    J Oral Biosci; 2021 Jun; 63(2):120-128. PubMed ID: 33839266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis.
    Miao J; Regan J; Cai C; Palmer GE; Williams DL; Kruppa MD; Peters BM
    mBio; 2023 Apr; 14(2):e0004623. PubMed ID: 36840583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
    Shao MK; Qi WJ; Hou MY; Luo DD
    J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
    Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Analysis of the Capacity of the
    Willems HME; Lowes DJ; Barker KS; Palmer GE; Peters BM
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling.
    Chen X; Wang J; Chen J; Wang G; Zhang R; Qiu J
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37573133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF; Olum R; Bongomin F
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High glucose-mediated overexpression of ICAM-1 in human vaginal epithelial cells increases adhesion of Candida albicans.
    Mikamo H; Yamagishi Y; Sugiyama H; Sadakata H; Miyazaki S; Sano T; Tomita T
    J Obstet Gynaecol; 2018 Feb; 38(2):226-230. PubMed ID: 28920516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Culture Supernatants of Lactobacillus gasseri and L. crispatus Inhibit Candida albicans Biofilm Formation and Adhesion to HeLa Cells.
    Matsuda Y; Cho O; Sugita T; Ogishima D; Takeda S
    Mycopathologia; 2018 Aug; 183(4):691-700. PubMed ID: 29603066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Syngonanthus nitens Bong. (Rhul.)-Loaded Nanostructured System for Vulvovaginal Candidiasis Treatment.
    Dos Santos Ramos MA; de Toledo LG; Calixto GM; Bonifácio BV; de Freitas Araújo MG; Dos Santos LC; de Almeida MT; Chorilli M; Bauab TM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
    de Souza ANV; Faria MGI; da Rocha CE; Philippsen GS; Silva GCC; da Silva GR; Inumaro RS; Gonçalves JE; Gazim ZC; Wietzikoski S; Lívero FADR; Seixas FAV; Wietzikoski Lovato EC
    J Ethnopharmacol; 2022 Sep; 295():115403. PubMed ID: 35643209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis.
    Sato MR; Oshiro-Junior JA; Rodero CF; Boni FI; Araújo VHS; Bauab TM; Nicholas D; Callan JF; Chorilli M
    J Mycol Med; 2022 Nov; 32(4):101296. PubMed ID: 35660541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibitory effects of butyl alcohol extract of Baitouweng decoction on yeast-to-hyphae transition of Candida albicans isolates from VVC in alkaline pH environment].
    Zhang MX; Xia D; Shi GX; Shao J; Wang TM; Tang CC; Wang CZ
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):710-5. PubMed ID: 26137695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
    Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis.
    Chen L; Wang Z; Liu L; Qu S; Mao Y; Peng X; Li YX; Tian J
    Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):9037-9055. PubMed ID: 31659418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.